Haridha Shivram

1.7k total citations · 1 hit paper
15 papers, 420 citations indexed

About

Haridha Shivram is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Haridha Shivram has authored 15 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 3 papers in Immunology and 3 papers in Cancer Research. Recurrent topics in Haridha Shivram's work include CRISPR and Genetic Engineering (4 papers), Cancer-related molecular mechanisms research (3 papers) and RNA Research and Splicing (3 papers). Haridha Shivram is often cited by papers focused on CRISPR and Genetic Engineering (4 papers), Cancer-related molecular mechanisms research (3 papers) and RNA Research and Splicing (3 papers). Haridha Shivram collaborates with scholars based in United States, Canada and Australia. Haridha Shivram's co-authors include Vishwanath R. Iyer, Jennifer A. Doudna, Brady F. Cress, Gavin J. Knott, Jared W. Ellefson, Raghav Shroff, Andrew D. Ellington, Jimmy Gollihar, Christof Fellmann and Rachel J. Lew and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and PLoS ONE.

In The Last Decade

Haridha Shivram

14 papers receiving 411 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Controlling and enhancing CRISPR systems

2020 136 citations Haridha Shivram, Brady F. Cress et al. Nature Chemical Biology profile →

Peers

Countries citing papers authored by Haridha Shivram

Since Specialization

Citations

This map shows the geographic impact of Haridha Shivram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haridha Shivram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haridha Shivram more than expected).

Fields of papers citing papers by Haridha Shivram

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haridha Shivram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haridha Shivram. The network helps show where Haridha Shivram may publish in the future.

Co-authorship network of co-authors of Haridha Shivram

This figure shows the co-authorship network connecting the top 25 collaborators of Haridha Shivram. A scholar is included among the top collaborators of Haridha Shivram based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haridha Shivram. Haridha Shivram is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Systemic cytokines drive conserved severity-associated myeloid responses across bacterial and viral infections 2025 ·Communications Biology ·Kimberly K. Kajihara, Donghong Yan, Gretchen Seim, (unknown), Jing‐Qiong Kang, Cynthia Chen, Marco De Simone, Tim Delemarre, Spyros Darmanis, Haridha Shivram, Rebecca N. Bauer, Carrie M. Rosenberger, Sharookh B. Kapadia, Min Xu, Miguel Reyes	0
2	Transcriptomic and proteomic assessment of tocilizumab response in a randomized controlled trial of patients hospitalized with COVID-19 2023 ·iScience ·Haridha Shivram, Jason A. Hackney, Carrie M. Rosenberger, Anastasia Teterina, Aditi Qamra, Olusegun O. Onabajo, Jacqueline McBride, Fang Cai, Min Bao, Larry Tsai, Aviv Regev, Iván O. Rosas, Rebecca N. Bauer	3
3	Prognostic value of severe acute respiratory syndrome coronavirus‐2 viral load and antibodies in patients hospitalized with COVID‐19 2023 ·Clinical and Translational Science ·Rebecca N. Bauer, Anastasia Teterina, Haridha Shivram, Jacqueline McBride, Carrie M. Rosenberger, Fang Cai, Min Bao, Larry Tsai, Oliver Gordon, Ivan T. Lee, Jeffrey J. Wallin, Danielle Porter, Kavita Juneja, Grégory Camus, Iván O. Rosas, Steffen Wildum	6
4	IgG Immune Complexes Inhibit Naïve T Cell Proliferation and Suppress Effector Function in Cytotoxic T Cells 2021 ·Frontiers in Immunology ·Wissam Charab, (unknown), Haridha Shivram, (unknown), Moses Donkor, (unknown), (unknown), (unknown), Jin Eyun Kim, Vishwanath R. Iyer, George Georgiou	5
5	Potent CRISPR-Cas9 inhibitors from Staphylococcus genomes 2020 ·Proceedings of the National Academy of Sciences ·Kyle E. Watters, Haridha Shivram, Christof Fellmann, Rachel J. Lew, (unknown), Jennifer A. Doudna	54
6	Controlling and enhancing CRISPR systems breakdown → 2020 ·Nature Chemical Biology ·Haridha Shivram, Brady F. Cress, Gavin J. Knott, Jennifer A. Doudna	136
7	ELF4 Is a Target of miR-124 and Promotes Neuroblastoma Proliferation and Undifferentiated State 2019 ·Molecular Cancer Research ·Adam Kosti, Liqin Du, Haridha Shivram, Qiao Mei, Suzanne S. Burns, (unknown), Alexander Pertsemlidis, Vishwanath R. Iyer, Erzsebet Kokovay, Luiz O. F. Penalva	15
8	MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 2019 ·Genome Research ·Haridha Shivram, (unknown), Vishwanath R. Iyer	13
9	PRC2 activates interferon-stimulated genes indirectly by repressing miRNAs in glioblastoma 2019 ·PLoS ONE ·Haridha Shivram, (unknown), Vishwanath R. Iyer	4
10	A Protein Antagonist of Activation-Induced Cytidine Deaminase Encoded by a Complex Mouse Retrovirus 2019 ·mBio ·(unknown), Hyewon Byun, (unknown), (unknown), Dennis Wylie, Haridha Shivram, Andrea K. Nash, Mary M. Lozano, Jaquelin P. Dudley	9
11	Bivalent Chromatin Domains in Glioblastoma Reveal a Subtype-Specific Signature of Glioma Stem Cells 2018 ·Cancer Research ·Amelia Weber Hall, Anna Battenhouse, Haridha Shivram, Adam R. Morris, Matthew C. Cowperthwaite, Max Shpak, Vishwanath R. Iyer	34
12	Identification and removal of sequencing artifacts produced by mispriming during reverse transcription in multiple RNA-seq technologies 2018 ·RNA ·Haridha Shivram, Vishwanath R. Iyer	15
13	Synthetic evolutionary origin of a proofreading reverse transcriptase 2016 ·Science ·Jared W. Ellefson, Jimmy Gollihar, Raghav Shroff, Haridha Shivram, Vishwanath R. Iyer, Andrew D. Ellington	93
14	Chd1 co-localizes with early transcription elongation factors independently of H3K36 methylation and releases stalled RNA polymerase II at introns 2014 ·Epigenetics & Chromatin ·Daechan Park, Haridha Shivram, Vishwanath R. Iyer	24
15	Targeting novel sites 2011 ·Mobile Genetic Elements ·Haridha Shivram, (unknown), Shawn M. Christensen	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact